ArticlePDF Available

Irritable Bowel Syndrome Is Positively Related to Metabolic Syndrome: A Population-Based Cross-Sectional Study

PLOS
PLOS One
Authors:

Abstract and Figures

Irritable bowel syndrome is a common gastrointestinal disorder that may affect dietary pattern, food digestion, and nutrient absorption. The nutrition-related factors are closely related to metabolic syndrome, implying that irritable bowel syndrome may be a potential risk factor for metabolic syndrome. However, few epidemiological studies are available which are related to this potential link. The purpose of this study is to determine whether irritable bowel syndrome is related to metabolic syndrome among middle-aged people. We designed a cross-sectional study of 1,096 subjects to evaluate the relationship between irritable bowel syndrome and metabolic syndrome and its components. Diagnosis of irritable bowel syndrome was based on the Japanese version of the Rome III Questionnaire. Metabolic syndrome was defined according to the criteria of the American Heart Association scientific statements of 2009. Dietary consumption was assessed via a validated food frequency questionnaire. Principal-components analysis was used to derive 3 major dietary patterns: "Japanese", "sweets-fruits", and "Izakaya (Japanese Pub) "from 39 food groups. The prevalence of irritable bowel syndrome and metabolic syndrome were 19.4% and 14.6%, respectively. No significant relationship was found between the dietary pattern factor score tertiles and irritable bowel syndrome. After adjustment for potential confounders (including dietary pattern), the odds ratio (95% confidence interval) of having metabolic syndrome and elevated triglycerides for subjects with irritable bowel syndrome as compared with non-irritable bowel syndrome are 2.01(1.13-3.55) and 1.50(1.03-2.18), respectively. Irritable bowel syndrome is significantly related to metabolic syndrome and it components. This study is the first to show that irritable bowel syndrome was significantly related to a higher prevalence of metabolic syndrome and elevated triglycerides among an adult population. The findings suggest that the treatment of irritable bowel syndrome may be a potentially beneficial factor for the prevention of metabolic syndrome. Further study is needed to clarify this association.
Content may be subject to copyright.
Irritable Bowel Syndrome Is Positively Related to
Metabolic Syndrome: A Population-Based Cross-
Sectional Study
Yinting Guo
1,2
, Kaijun Niu
1
*, Haruki Momma
3
, Yoritoshi Kobayashi
3
, Masahiko Chujo
3
, Atsushi Otomo
3
,
Shin Fukudo
2
, Ryoichi Nagatomi
3
1Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China, 2Department of Behavioral Medicine, Tohoku University
Graduate School of Medicine, Sendai, Japan, 3Division of Biomedical Engineering for Health & Welfare, Tohoku University Graduate School of Biomedical Engineering,
Sendai, Japan
Abstract
Irritable bowel syndrome is a common gastrointestinal disorder that may affect dietary pattern, food digestion, and nutrient
absorption. The nutrition-related factors are closely related to metabolic syndrome, implying that irritable bowel syndrome
may be a potential risk factor for metabolic syndrome. However, few epidemiological studies are available which are related
to this potential link. The purpose of this study is to determine whether irritable bowel syndrome is related to metabolic
syndrome among middle-aged people. We designed a cross-sectional study of 1,096 subjects to evaluate the relationship
between irritable bowel syndrome and metabolic syndrome and its components. Diagnosis of irritable bowel syndrome was
based on the Japanese version of the Rome III Questionnaire. Metabolic syndrome was defined according to the criteria of
the American Heart Association scientific statements of 2009. Dietary consumption was assessed via a validated food
frequency questionnaire. Principal-components analysis was used to derive 3 major dietary patterns: ‘‘Japanese’’, ‘‘sweets-
fruits’’, and ‘‘Izakaya (Japanese Pub) ‘‘from 39 food groups. The prevalence of irritable bowel syndrome and metabolic
syndrome were 19.4% and 14.6%, respectively. No significant relationship was found between the dietary pattern factor
score tertiles and irritable bowel syndrome. After adjustment for potential confounders (including dietary pattern), the odds
ratio (95% confidence interval) of having metabolic syndrome and elevated triglycerides for subjects with irritable bowel
syndrome as compared with non-irritable bowel syndrome are 2.01(1.13–3.55) and 1.50(1.03–2.18), respectively. Irritable
bowel syndrome is significantly related to metabolic syndrome and it components. This study is the first to show that
irritable bowel syndrome was significantly related to a higher prevalence of metabolic syndrome and elevated triglycerides
among an adult population. The findings suggest that the treatment of irritable bowel syndrome may be a potentially
beneficial factor for the prevention of metabolic syndrome. Further study is needed to clarify this association.
Citation: Guo Y, Niu K, Momma H, Kobayashi Y, Chujo M, et al. (2014) Irritable Bowel Syndrome Is Positively Related to Metabolic Syndrome: A Population-Based
Cross-Sectional Study. PLoS ONE 9(11): e112289. doi:10.1371/journal.pone.0112289
Editor: Andreas Zirlik, University Heart Center Freiburg, Germany
Received January 27, 2014; Accepted October 14, 2014; Published November 10, 2014
Copyright: 2014 Guo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by a Grant-in-Aid for ‘‘Knowledge Cluster Initiative’’ from the Ministry of Education, Culture, Sports, Science and Technology
of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: All the authors have no conflicts of interest exists to disclose.
* Email: nkj0809@163.com
Introduction
Irritable bowel syndrome (IBS) is a common gastrointestinal
disorder characterized by episodes of recurrent abdominal pain or
discomfort related to disturbed bowel habits [1,2]. The majority of
subjects with IBS are conscious that diet may play a role in
triggering these episodes and therefore may avoid certain foods
and changes in their dietary pattern [3–8]. Furthermore, IBS
disrupts the digestion of food, or directly interferes with nutrient
absorption [9–11].
Metabolic syndrome (MS) is a well-recognized constellation of
risk factors for cardiovascular disease (CVD) [12], which remains a
major cause of mortality and morbidity worldwide [13]. Accu-
mulated evidence suggests that dietary factors are the cornerstone
for the prevention and treatment of MS [14–16]. Furthermore,
with respect to dietary factors studies, researchers have usually
focused predominantly on the effects of individual nutrients and
sometimes foods, but rarely on dietary patterns. However, daily
diets are composed of a wide variety of foods containing complex
combinations of nutrients. The surveys that examine a single
nutrient in foods, or a single food, may not adequately account for
complicated interactions and cumulative effects on human health.
Therefore, compared with a single nutrient in foods or a single
food, a dietary pattern study may be a more important tool for
evaluation of the effects of diet on health [17,18].
Irritable bowel syndrome status may affect the dietary pattern,
food digestion, and nutrient absorption, which are important
factors for the prevention and treatment of MS and/or its
components. Therefore, it is speculated that IBS may be a
potential risk factor for MS. However, few epidemiological studies
have assessed the relationship between IBS status and MS and its
components in an adult population.
At present, we have designed a cross-sectional study to
determine whether IBS is related to MS among middle-aged
people.
PLOS ONE | www.plosone.org 1 November 2014 | Volume 9 | Issue 11 | e112289
Materials and Methods
Study Population
The current analysis uses data from a population-based
longitudinal study designed to investigate the lifestyle risk factors
of CVD among Japanese adults. The methods are described in
detail elsewhere [19,20].
There were 1,208 subjects who had received a health
examination including blood examinations in 2011. Of these,
1,163 subjects agreed to participate and provided informed
consent for their data to be analyzed. Subjects were excluded if
they did not provide any dietary information (n = 21) or did not
answer the Rome III Modular Questionnaire (n = 46). Owing to
these exclusions, the final cross-sectional study population
comprised 1,096 subjects (mean [standard deviation, SD] age:
46.2 [11.2] years; male, 77.5%). The Institutional Review Board of
the Tohoku University Graduate School of Medicine approved the
study protocol.
Assessment of IBS
The Japanese version of the Rome III Questionnaire was used
to screen for IBS [21]. All subjects were asked to complete self-
reported ROME III diagnostic questionnaires. Screening for IBS
requires that subjects have abdominal discomfort or pain lasting at
least 3 days per month, not necessarily consecutive, during the
previous 3 months which is associated with 2 or more of the
following: relief by defecation; onset associated with a change in
frequency of stool; onset associated with a change in form
(appearance) of stool.
Assessment of MS and Other
Waist circumference was measured at the umbilical level with
participants standing and breathing normally. Blood pressure (BP)
was measured twice from the upper left arm using a YA-
MASU605P automatic device (Kenzmedico, Saitama, Japan) after
5 min of rest in the seated position. The mean of these 2
measurements was taken as the BP value. Blood samples were
collected in siliconized vacuum glass tubes containing sodium
fluoride, for the analysis of fasting blood glucose (FBG), or
containing no additives, for the analysis of lipids. Fasting blood
glucose was measured by using enzymatic methods (Eerotec,
Tokyo, Japan). The concentrations of triglycerides (TG), low-
density lipoprotein cholesterol (LDL), and high-density lipoprotein
cholesterol (HDL) were measured by enzymatic methods using
appropriate kits (Sekisui Medical, Tokyo, Japan). Serum high-
sensitive C-reactive protein (hsCRP) levels were determined using
N-latex CRP-2 (Siemens Healthcare Japan, Tokyo, Japan). The
measurement limit of hsCRP was 0.02 mg/L and an hsCRP value
less than the measurement limit was considered to be 0.01 mg/L.
Metabolic syndrome was defined in accordance with the criteria
of the American Heart Association scientific statements of 2009
[22]. Participants were considered to have MS when they
presented three or more of the following components: 1) elevated
waist circumference for Asian individuals ($90 cm and $80 cm in
male and female, respectively), 2) elevated TG ($150 mg/dL), or
drug treatment for elevated TG, 3) reduced HDL (,40 mg/dL in
male; ,50 mg/dL in female) or drug treatment for reduced HDL,
4) elevated blood pressure (SBP $130 mm Hg and/or DBP $
85 mm Hg) or antihypertensive drug treatment, 5) elevated fasting
glucose ($100 mg/dL) or drug treatment of elevated glucose.
Assessment of Dietary Intake
The subjects were instructed to complete a brief, self-adminis-
tered diet history questionnaire (BDHQ) that included questions
on 75 food items along with their specified serving sizes, described
in terms of natural portions or standard weights and volume
measures of the servings, commonly consumed by the study
population. For each food item, the subjects indicated their mean
frequency of consumption of the food over the past month in terms
of the specified serving size by checking 1 of the 7 frequency
categories, ranging from ‘‘almost never’’ to ‘‘2 or more times/
day’’. The mean daily consumption of nutrients was calculated
using an ad hoc computer program developed to analyze the
questionnaire. The Japanese food composition tables, 5
th
edition,
[23] and other [24] were used as the nutrient database. The
reproducibility and validity of the BDHQ have already been
described in detail elsewhere [25]. Foods from the BDHQ were
categorized into 39 food subgroups, which were used to derive
dietary patterns via principal-components analysis.
Factor analysis (principal-components analysis) was used to
derive dietary patterns and to determine factor loadings for each of
the 39 food subgroups (in g/d) [26]. Factors were rotated with
varimax rotation to maintain uncorrelated factors and enhance
interpretability [27]. A combined evaluation of the eigenvalues,
scree plot test, and factor interpretability was used in determining
the number of retained factors. The distinctive dietary patterns of
the study population were well described by the 3 factors. Factors
were named descriptively according to the food items showing
high loading (absolute value) with respect to each dietary pattern
as follows: ‘‘Japanese’’ dietary pattern (factor 1), ‘‘sweets-fruits’’
pattern (factor 2), and ‘‘Izakaya (Japanese Pub)’’ pattern (factor 3)
(see Table S1). For each dietary pattern and each subject, we
calculated a factor score by summing the consumption from each
food item weighted by its factor loading as follows [27]:
Xfood groupiservings=dðÞ|food groupifactor loadingðÞ½Þ
where i= food groups 1–39. A higher factor score indicates
greater conformity to the dietary pattern. Variables unrelated to a
given dietary pattern are weighted close to zero. For further
analyses, factor scores were categorized into 3 equal groups by
using tertiles cutoffs.
Assessment of Other Variables
Sociodemographic variables, including age, gender, and edu-
cational levels were also assessed. The educational level was
assessed by determining the last grade level and was divided into 2
categories: ,college or $college. Body mass index (BMI) was
calculated as weight in kilograms divided by squared height in
meters (kg/m2). History of physical illness and current medication
were noted from ‘‘yes’’ or ‘‘no’’ responses to relevant questions.
Information on smoking status, and drinking status were obtained
from a questionnaire survey. Levels of daily physical activity (PA)
were estimated using the International Physical Activity Ques-
tionnaire (IPAQ) (Japanese version) [28]. Total daily PA
(metabolic equivalents [METs]6hours/week) were calculated as
follows: (daily hours of walking 6days per week with
walking63.3)+(daily hours of moderate-intensity activity6days
per week with moderate-intensity activity64.0)+(daily hours of
vigorous activity6days per week with vigorous activity68.0). The
METs values were derived from the IPAQ validity and reliability
study [28]. Physical activity was categorized into three groups: no
PA, low PA (0,PA,23 METs 6hours/week), and high PA ($23
METs6hours/week) [29]. Depressive symptoms were assessed
according to the Japanese version of the Self-Rating Depression
Scale (SDS) [30]. An SDS score $45 was taken as the cutoff point
indicating depressive symptoms [31].
Irritable Bowel Syndrome & Metabolic Syndrome
PLOS ONE | www.plosone.org 2 November 2014 | Volume 9 | Issue 11 | e112289
Statistical Analysis
All statistical analyses were performed using the Statistical
Analysis System 9.1 edition for Windows (SAS Institute Inc., Cary,
NC, USA). The age- and sex-adjusted variable differences
according to IBS status were examined by analysis of covariance
(ANCOVA) for continuous variables or by the multiple logistic
regression analysis for variables of proportion. For main analysis,
the MS or its components were used as a dependent variable and
IBS status as independent variables. The odds ratio (OR) and 95%
confidence interval (CI) of MS and its components compared with
IBS status were calculated using multiple logistic regression
analysis. We used age, sex, BMI, smoking and drinking status,
educational level, PA levels, dietary patterns, total energy intake,
depressive symptoms and mutual metabolic syndrome components
as covariates for multiple adjustments. Model fit was evaluated
using the Hosmer-Lemeshow goodness-of-fit statistic. For all
models, the test was not significant (P$0.31). Interactions between
IBS status and confounders of MS or its components were tested
by the addition of cross-product terms to the regression model. All
tests were two-tailed and P,0.05 was defined as statistically
significant.
Results
Among 1,096 subjects who were available to be analyzed, 213
(19.4%) had self-reported IBS, and 160 (14.6%) had MS.
Age- and sex-adjusted characteristics of study subjects with and
without IBS are presented in Table 1. Subjects with IBS were
significantly younger than the non-IBS subjects (P,0.01) with a
mean (95% CI) 43.4 (41.9–45.0) y compared to 46.1 (45.3–47.0) y.
Subjects with IBS contained a lower proportion of males, and a
higher proportion of ex-smokers and depressive symptoms (P,
0.05 for all comparisons). Compared to subjects with IBS, the non-
IBS subjects had lower total energy intake, and serum TG levels
(P,0.05 for all comparisons).
Because IBS may affect the dietary pattern [32], as an initial
step, we evaluated the relationships between dietary patterns and
IBS. Three major dietary patterns were identified by factor
analysis (Table S1). Factor 1, identified as a traditional
‘‘Japanese’’ dietary pattern was characterized by a high consump-
tion of vegetables, seaweeds, soybean products, fish, fruits, miso
soup, and green tea. Factor 2 was typified by a greater
consumption of cake, ice cream, fruits, bread, dairy products,
mayonnaise and lower consumption of alcohol (named the
‘‘sweets-fruits’’ pattern). Factor 3 was typified by a greater
consumption of noodles, Squid, octopus, lobster, shellfish, meat,
fish, cola, alcohol, coffee, mayonnaise, chicken egg, and bread
(named the ‘‘Izakaya (Japanese Pub)’’ pattern). These 3 patterns
explained 32.1% of the variance in dietary consumption (18.6%
for factor 1, 7.5% for factor 2, and 6.0% for factor 3). Increasing
the number of patterns did not materially increase the total
proportion of variance in dietary consumption explained by the
model. Daily food and nutrient consumption are presented
according to tertiles of dietary pattern factor score in Table S2.
Compared to subjects with factor scores in the lowest tertile for the
‘‘Japanese’’ dietary pattern, those in the highest tertile had a
higher consumption of total meats, total fish, seaweeds, total
vegetables, soybean products, total fruits, dairy products, green
tea, black or oolong tea, total energy intake, animal protein,
vegetable protein, animal fat, vegetable fat, carbohydrate, total
fiber, calcium, and eicosapentaenoic acid (EPA) +docosahexae-
noic acid (DHA), and lower consumptions of cola (Pfor trend ,
0.05). Compared to those in the middle ‘‘sweets-fruits’’ pattern
tertile, subjects in the highest tertile had significant higher
consumptions of total fish, total seaweeds, total vegetables, total
fruit, dairy products, green tea, cola, total energy intake, animal
protein, vegetable protein, animal fat, vegetable fat, carbohydrate,
total fiber, calcium, EPA+DHA, and a lower consumption of
alcohol (P,0.05). Compared to those in the lowest ‘‘Izakaya
(Japanese Pub)’’ pattern tertile, subjects in the highest tertile had a
higher consumption of total meats, total fish, seaweeds, coffee,
cola, total energy intake, animal protein, vegetable protein, animal
fat, vegetable fat, carbohydrate, total fiber, calcium, EPA+DHA,
alcohol, lower consumption of total fruits, and dairy products (P
for trend ,0.01). The age- and sex-adjusted relationships between
tertiles of dietary pattern factor score and IBS status are indicated
in Table 1. No significant relationships between the tertiles of
each dietary pattern and IBS status were observed. These results
were unchanged when we adjusted for multiple confounding
factors (see Table 2 model 5) (P.0.15 for all comparisons).
We next investigated whether IBS status is related to MS and its
components. Table 2 shows the adjusted relationships between
IBS status and MS and its components. In the final multivariate
models, the adjusted ORs (95% CI) of MS related to IBS group as
compared with the non-IBS group is 2.01 (1.13–3.55). In MS
components analysis, IBS status was only positively related to
elevated TG in the final model (OR [95% CI]: 1.50 [1.03–2.18]).
Although the difference was not statistically significant, the
proportion of subjects with elevated waist circumference was
higher in IBS group (OR [95% CI]: 1.60 [0.85–2.96]) in the final
multivariate models. No significant relationships were observed
between IBS status and other MS components in the final
multivariate models. The tests for interactions between IBS status
and other potential confounders in the final models were also not
statistically significant (interaction P values.0.22).
Discussion
In this cross-sectional study, we investigated the relationships
between IBS and MS in an adult population. This study is the first
to show that IBS is independently related to a higher prevalence of
MS and elevated TG. Further, no significant relationships between
IBS and dietary patterns were observed.
In this study, we adjusted for various potential confounders
related to IBS and/or MS. First, we considered that age, sex (see
Table 1), and body mass index [33] were potential confounders.
Second, the effect of lifestyle factors, such as smoking [33] and
drinking status [34], physical activity [35], and educational level
[36], were adjusted. Moreover, IBS can affect dietary intake and
thus affect the dietary pattern. Furthermore, dietary factors are
also important for incidence of MS [35]. Accordingly, we made
adjustments for total energy intake, and dietary pattern. Third,
depressive symptoms are also closely related to IBS (see Table 1)
and MS [37]. However, adjustments for these confounding factors
did not change the significant positive relationship between IBS
and MS. That is, the positive relationship between IBS and MS
was independent of these factors.
It is hypothesized that IBS has a potentially adverse effect on
MS and its components possibly due to effect on dietary pattern,
food digestion, or nutrient absorption. However, no significant
relationships between IBS and dietary patterns were observed.
The result was similar to a previous study, suggesting that IBS is
not related to dietary habits and/or nutritional intake [38].
Furthermore, although several studies have demonstrated self-
reported food intolerances in most patients with IBS [3–8], two
other studies have indicated that those with IBS appear to have
adequate and balanced food and macronutrient intake, with no
evidence of inadequate micronutrient intake [39,40]. Therefore,
Irritable Bowel Syndrome & Metabolic Syndrome
PLOS ONE | www.plosone.org 3 November 2014 | Volume 9 | Issue 11 | e112289
we consider that while IBS symptoms affect the choice of certain
specific food items, it has no essential impact on dietary pattern or
the intake of nutrients. In the modern world, especially in
developed countries, a variety of different foods are available in
daily life. The availability of these choices may well make up for
IBS symptoms-bringing harmful effects from certain food items.
Further study is needed to confirm this hypothesis.
Despite underlying causes of pathophysiologic changes still not
being completely understood, low grade mucosal inflammation,
increased intestinal mucosal permeability, and abnormal intestinal
motility are accepted mechanisms which alter gut function and
Table 1. Age- and sex-adjusted characteristics of the subjects in relation to irritable bowel syndrome (n = 1,096)
{
Irritable bowel syndrome
P
value
`
No (n = 883) Yes (n = 213)
Age (y) 46.1 (45.3–47.0)
1
43.4 (41.9–45.0) ,0.01
Sex (male, %) 79.2 70.4 0.02
BMI (kg/m2) 22.8 (22.5–23.0) 22.6 (22.1–23.1) 0.54
Smoking status (%)
Current smoking 40.8 36.6 0.46
Ex-smoking 12.5 17.4 0.049
Never-smoking 46.6 46.0 0.53
Drinking status (%)
Daily 28.3 25.4 0.77
Sometimes 48.5 50.2 0.93
Never-drinking 23.2 24.4 0.89
Educational level ($college, %) 33.8 28.2 0.14
PA (%)
0 METs hours/week 25.4 23.5 0.50
0–23 METs hours/week 39.9 44.6 0.37
$23 METs hours/week 34.8 31.9 0.76
Total energy intake (kcal/d) 1733.0 (1686.7–1779.4) 1836.6 (1754.4–1918.7) 0.02
‘‘Japanese’’ dietary pattern
The lowest tertile of factor score 32.7 35.7 0.85
The middle tertile of factor score 33.9 31.5 0.41
The highest tertile of factor score 33.4 32.9 0.48
‘‘sweets-fruits’’ dietary pattern
The lowest tertile of factor score 34.4 28.6 0.37
The middle tertile of factor score 33.6 32.4 0.44
The highest tertile of factor score 31.9 39.0 0.09
‘‘Izakaya (Japanese Pub)’’ dietary pattern
The lowest tertile of factor score 33.8 31.5 0.24
The middle tertile of factor score 33.9 31.5 0.55
The highest tertile of factor score 32.4 37.1 0.08
Depressive symptoms (SDS $45, %) 30.9 42.7 ,0.01
Waist (cm) 80.2 (79.5–81.0) 80.6 (79.3–81.9) 0.61
SBP (mmHg) 122.1 (120.9–123.2) 121.6 (119.6–123.6) 0.67
DBP (mmHg) 75.7 (74.8–76.5) 75.1 (73.6–76.6) 0.49
Log translated TG (mg/dl)
"
86.5 (82.7–90.5) 98.4 (90.9–106.5) ,0.01
FBG (mg/dl) 96.7 (94.8–98.6) 96.4 (93.0–99.7) 0.85
HDL (mg/dl) 62.6 (61.5–63.7) 61.5 (59.6–63.4) 0.31
LDL (mg/dl) 114.1 (111.7–116.4) 114.5 (110.2–118.7) 0.87
Log translated hsCRP (mg/L)
"
0.32 (0.29–0.35) 0.30 (0.26–0.36) 0.64
{
BMI, body mass index; PA, physical activity; METs, metabolic equivalents; SDS, Self-rating Depression Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure;
TG, triglyceride; FBG, fasting blood glucose; HDL, high-density lipoprotein-cholesterol; LDL, low-density lipoprotein; hsCRP, high-sensitivity C-reactive protein.
`
Analysis of covariance or logistic regression analysis adjusted for age and sex where appropriate.
1
Adjusted least squares mean (95% confidence interval) (all such values).
"
Adjusted geometric mean (95% confidence interval).
doi:10.1371/journal.pone.0112289.t001
Irritable Bowel Syndrome & Metabolic Syndrome
PLOS ONE | www.plosone.org 4 November 2014 | Volume 9 | Issue 11 | e112289
generate symptoms of IBS [41]. The response of the gastrointes-
tinal tract to ingestion of food is a complex and closely controlled
process, which allows optimization of propulsion, digestion,
absorption of nutrients, and removal of indigestible remnants.
Therefore, it is believed that IBS is an important risk factor in the
digestion of food and in nutrient absorption. Many studies have
investigated the effects of IBS on the digestion of food or nutrient
absorption [9–11]. These studies have consistently demonstrated
that increased and discordant absorption of some nutrients, such
as mannitol and sorbitol occurs in subjects with IBS compared to
healthy controls [9–11]. In the present study, we found that IBS is
mainly related to elevated TG, suggesting that IBS may affect the
digestion and absorption of fats in the gastrointestinal tract. In fact,
several studies have evaluated the relationships between IBS and
the digestion and absorption of fats [8,42]. Simren et al. have
reported IBS to be related to increased colonic sensitivity and an
altered viscerosomatic referral pattern after duodenal lipids
infusion [42]. Another study also indicated that gastrointestinal
symptoms were frequently reported after intake of fried and fatty
foods in IBS patients [8]. Therefore, we consider the relationship
between IBS and MS and its components to be possibly due to the
disorder of food digestion and nutrient absorption, especially in the
fat components. This study, which was designed to investigate the
relationships between IBS and MS, is very limited and we
therefore cannot determine an exact mechanism to explain our
observations. Further studies are needed to make certain the
causality and exact mechanisms of IBS in MS.
On the other hand, gut microbiota alterations could also be
considered a potential link between IBS and MS and its
components. The accumulated evidence has indicated that IBS
is related to quantitative and qualitative changes in gut microbiota
[43]. Because the gut microbiota is becoming known as a more
and more important risk factor for the treatment and prevention of
MS [44,45], there is conjecture that IBS may be a potential risk
factor for MS due to the effect of IBS on the quantitative and
qualitative changes of gut microbiota. Further studies are needed
to clarify this hypothesis.
A small-scale case-control study has shown that IBS was
significantly related to a higher FBS and higher prevalence of
prediabetes than in the control group [46]. In contrast, the present
study did not find significant relationships between IBS and FBG
or elevated FBG. Although the reason remains unclear, differences
in age (mean age is 46.2 y in our study vs 33.0 y in their study),
adjustment factors (all lifestyle factors were adjusted in their study)
and population size may partly explain the discrepancy. Further
study is needed to investigate this issue.
To the best of our knowledge, no previous study has examined
the relationships between dietary pattern and IBS among the
general population. The present study first investigated the
relationships between dietary patterns and IBS in apparently
healthy adults. The results suggest that dietary patterns were not
related to the prevalence of IBS. Furthermore, the traditional
Japanese diet is a well-known healthy diet pattern [26,47]. Thus,
we also evaluated whether the traditional Japanese dietary pattern
was significantly related to a lower prevalence of IBS. The results
indicated that no significant relationships between traditional
Japanese dietary patterns and IBS were observed. Further study is
needed to make certain of our observations.
This study had several limitations. First, the Rome III
questionnaire is designed for the measurement and screening of
IBS, not for making a clinical diagnosis. Therefore, a population
study that uses a standardized comprehensive structured diagnos-
tic interview should be undertaken to confirm the influence of IBS
on MS. Second, because this study was a cross-sectional study, we
could not conclude that IBS increases the occurrence of MS or
that MS leads to episodes of IBS in adult populations. Therefore, a
prospective study or trial should be undertaken to confirm the
existence of a relationship between IBS, and MS and elevated TG.
In the present study, IBS was significantly related to a higher
prevalence of MS and elevated TG among an adult population.
The differences in dietary patterns are not likely to explain our
findings. The findings suggest that the treatment of IBS may be a
potentially beneficial factor for the development and prevention of
MS. Further study is required to clarify this causality.
Supporting Information
Table S1 Principal components analysis varimax-rotated 39
food groups factor loading scores (n = 1,096).
(DOC)
Table 2. Adjusted odds ratios and 95% confidence interval for the relationship between MS and IBS (n = 1,096)
{
IBS vs non IBS
Model 1
`
Model 2
1
Model 3
"
Model 4 Model 5
|
MS 1.85 (1.05–3.20) 1.94 (1.10–3.37) 2.01 (1.13–3.52) 2.01 (1.13–3.55) -
MS components
Waist circumference $90 cm for male
or $80 cm for female
1.61 (0.89–2.92) 1.68 (0.91–3.06) 1.64 (0.88–3.03) 1.60 (0.86–2.97) 1.60 (0.85–2.96)
Triglycerides $150 mg/dL 1.52 (1.05–2.18) 1.53 (1.06–2.20) 1.52 (1.04–2.19) 1.51 (1.04–2.19) 1.50 (1.03–2.18)
HDL-cholesterol ,40 mg/dL 1.04 (0.56–1.85) 0.99 (0.51–1.80) 1.00 (0.52–1.83) 1.04 (0.53–1.92) 1.00 (0.51–1.85)
SBP $130 mmHg or DBP $85 mmHg 1.04 (0.74–1.48) 1.03 (0.72–1.47) 1.05 (0.73–1.51) 1.06 (0.74–1.53) 1.04 (0.72–1.50)
High fasting glucose $100 mg/dL 1.27 (0.74–2.11) 1.24 (0.72–2.07) 1.26 (0.73–2.12) 1.25 (0.72–2.11) 1.19 (0.68–2.03)
{
MS, metabolic syndrome; IBS, irritable bowel syndrome; HDL, high-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure.
`
Adjusted for age, sex and body mass index.
1
Additionally adjusted for smoking and drinking status, educational level, and physical activity.
"
Additionally adjusted for dietary patterns, and total energy intake.
Additionally adjusted for depressive symptoms.
|
Additionally adjusted for mutual metabolic syndrome components.
doi:10.1371/journal.pone.0112289.t002
Irritable Bowel Syndrome & Metabolic Syndrome
PLOS ONE | www.plosone.org 5 November 2014 | Volume 9 | Issue 11 | e112289
Table S2 Daily food and nutrient consumption of the partici-
pants according to the tertiles of dietary pattern factor score
(n = 1,096).
(DOC)
Acknowledgments
We gratefully acknowledge all the men and women who participated in the
study and Sendai Oroshisho Center for the possibility to perform the study.
Author Contributions
Conceived and designed the experiments: KN SF RN. Performed the
experiments: YG KN HM YK MC AO. Analyzed the data: YG KN.
Contributed reagents/materials/analysis tools: YG KN. Wrote the paper:
YG KN. Critical revision of the manuscript for important intellectual
content: YG KN SF RN.
References
1. Camilleri M (2001) Management of the irritable bowel syndrome. Gastroenter-
ology 120: 652–668.
2. Chang L (2004) Review article: epidemiology and quality of life in functional
gastrointestinal disorders. Aliment Pharmacol Ther 20 Suppl 7: 31–39.
3. Hayes P, Corish C, O’Mahony E, Quigley EM (2013) A dietary survey of
patients with irritable bowel syndrome. J Hum Nutr Diet: (in press. doi:
10.1111/jhn.12114).
4. Feinle-Bisset C, Azpiroz F (2013) Dietary lipids and functional gastrointestinal
disorders. Am J Gastroenterol 108: 737–747.
5. Simren M, Mansson A, Langkilde AM, Sved lund J, Abrahamsson H, et al.
(2001) Food-related gastrointestinal symptoms in the irritable bowel syndrome.
Digestion 63: 108–115.
6. Park HJ, Jarrett M, Heitkemper M (2010) Quality of life and sugar and fiber
intake in women with irritable bowel syndrome. West J Nurs Res 32: 218–232.
7. Aller R, de Luis DA, Izaola O, La Calle F, del Olmo L, et al. (2004) [Dietary
intake of a group of patients with irritable bowel syndrome; relation between
dietary fiber and symptoms]. An Med Interna 21: 577–580.
8. Bohn L, Storsrud S, Tornblom H, Bengtsson U, Simren M (2013) Self-reported
food-related gastrointestinal symptoms in IBS are common and associated with
more severe symptoms and redu ced quality of life. Am J Gastroenterol 108:
634–641.
9. Marciani L, Cox EF, Hoad CL, Pritchard S, Totman JJ, et al. (2010)
Postprandial changes in small bowel water content in healthy subjects and
patients with irritable bowel syndrome. Gastroenterology 138: 469–477, 477
e461.
10. Keller J, Layer P (2009) Intestinal and anorectal motility and functional
disorders. Best Pract Res Clin Gastroenterol 23: 407–423.
11. Yao CK, Tan HL, van Langenberg DR, Barrett JS, Rose R, et al. (2013) Dietary
sorbitol and mannitol: food content and distinct absorption patterns between
healthy individuals and patients with irritable bowel syndrome. J Hum Nutr
Diet.
12. Nikolopoulou A, Kadoglou NP (2012) Obesity and metabolic syndrome as
related to cardiovascular disease. Expert Rev Cardiovasc Ther 10: 933–939.
13. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and
regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:
a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:
2095–2128.
14. Nestel P (2004) Nutritional aspects in the causation and management of the
metabolic syndrome. Endocrinol Metab Clin North Am 33: 483–492, v.
15. Josse AR, Jenkins DJ, Kendall CW (2008) Nutritional determinants of the
metabolic syndrome. J Nutrigenet Nutrigenomics 1: 109–117.
16. Leao LS, de Moraes MM, de Carvalho GX, Koifman RJ (2011) Nutritional
interventions in metabolic syndrome: a systematic review. Arq Bras Cardiol 97:
260–265.
17. Willett WC, McCullough ML (2008) Dietary pattern analysis for the evaluation
of dietary guidelines. Asia Pac J Clin Nutr 17 Suppl 1: 75–78.
18. Hu FB (2002) Dietary pattern analysis: a new direction in nutritional
epidemiology. Curr Opin Lipidol 13: 3–9.
19. Niu K, Kobayashi Y, Guan L, Monma H, Guo H, et al. (2013) Low-fat dairy,
but not whole-/high-fat dairy, consumption is related with higher serum
adiponectin levels in apparently healthy adults. Eur J Nutr 52: 771–778.
20. Niu K, Kobayashi Y, Guan L, Momma H, Guo H, et al. (2013) Longitudinal
changes in the relationship between serum adiponectin concentration and
cardiovascular risk factors among apparently healthy middle-aged adults.
Int J Cardiol: (http://dx.doi.org/10.1016/j.bbr.2011.1003.1031).
21. Fukudo S, Hongo M, Matsueda K, Drossman DA (2008) The Japanese Version
of Rome III: the Functional Gastrointestinal Disorders, 3rd edn. Tokyo:
KYOWA KIKAKU Ltd,.
22. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009)
Harmonizing the metabolic syndrome: a joint interim statement of the
International Diabetes Federation Task Force on Epidemiology and Prevention;
National Heart, Lung, and Blood Institute; American Heart Association; World
Heart Federation; International Atherosclerosis Society; and International
Association for the Study of Obesity. Circulation 120: 1640–1645.
23. Science and Technology Agency: Standard Tables of Food Composition in
Japan (Fifth revised edition). Printing Buteau, Ministry of Finance, Tokyo, 2000
(in Japanese).
24. Sakai K, Nakajima M, Watanabe S, Kobayashi T (1995) Available data on
assessments of dietary fatty acid intake. J Lipid Nutr 4: 97–103 (in Japanese).
25. Sasaki S (2005) Serum Biomarker-based Validation of a Brief-type Self-
administered Diet History Questionnaire for Japanese Subjects, The Study
Group of Ministry of Health, Labor and Welfare of Japan, Tanaka H, chairman,
‘‘A research for assessment of nutrition and dietary habit in ‘‘Kenko Nippon 21’’.
Tokyo: 10–42 (in Japanese).
26. Guo H, Niu K, Monma H, Kobayashi Y, Guan L, et al. (2012) Association of
Japanese dietary pattern with serum adiponectin concentration in Japanese adult
men. Nutr Metab Cardiovasc Dis 22: 277–284.
27. Kim J, Mueller C (1978) Factor Analysis: Statistical Methods and Practical
Issues. Beverly Hills, Calif: Sage Publications;.
28. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, et al. (2003)
International physical activity questionnaire: 12-country reliability and validity.
Med Sci Sports Exerc 35: 1381–1395.
29. Ishikawa-Takata K, Tabata I (2007) Exercise and Physical Activity Reference
for Health Promotion 2006 (EPAR2006). J Epidemiol 17: 177.
30. Fukuda K, Kobayashi S (1973) A study on a self-rating depression scale.
Psychiatria et Neurologia Japonica 75: 673–679 (in Japanese).
31. Barrett J, Hurst MW, DiScala C, Rose RM (1978) Prevalence of depression over
a 12-month period in a nonpatient population. Arch Gen Psychiatry 35: 741–
744.
32. Morcos A, Dinan T, Quigley EM (2009) Irritable bowel syndrome: role of food
in pathogenesis and management. J Dig Dis 10: 237–246.
33. Cena H, Fonte ML, Turconi G (2011) Relationship between smoking and
metabolic syndrome. Nutr Rev 69: 745–753.
34. Alkerwi A, Boutsen M, Vaillant M, Barre J, Lair ML, et al. (2009) Alcohol
consumption and the prevalence of metabolic syndrome: a meta-analysis of
observational studies. Atherosclerosis 204: 624–635.
35. Yamaoka K, Tango T (2012) Effects of lifestyle modification on metabolic
syndrome: a systematic review and meta-analysis. BMC Med 10: 138.
36. Li YQ, Zhao LQ, Liu XY, Wang HL, Wang XH, et al. (2013) Prevalence and
distribution of metabolic syndrome in a southern Chinese population. Relation
to exercise, smoking, and educational level. Saudi Med J 34: 929–936.
37. Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, et al. (2012) Bidirectional
association between depression and metabolic syndrome: a systematic review
and meta-analysis of epidemiological studies. Diabetes Care 35: 1171–1180.
38. Jung HJ, Park MI, Moon W, Park SJ, Kim HH, et al. (2011) Are Food
Constituents Relevant to the Irritable Bowel Syndrome in Young Adults? - A
Rome III Based Prevalence Study of the Korean Medical Students.
J Neurogastroenterol Motil 17: 294–299.
39. Williams EA, Nai X, Corfe BM (2011) Dietary intakes in people with irritable
bowel syndrome. BMC Gastroenterol 11: 9.
40. Saito YA, Locke GR 3rd, Weaver AL, Zinsmeister AR, Talley NJ (2005) Diet
and functional gastrointestinal disorders: a population-based case-control study.
Am J Gastroenterol 100: 2743–2748.
41. Camilleri M, Lasch K, Zhou W (2012) Irritable bowel syndrome: methods,
mechanisms, and pathophysiology. The confluence of increased permeability,
inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest
Liver Physiol 303: G775–785.
42. Simren M, Abrahamsson H, Bjornsson ES (2007) Lipid-induced colonic
hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex,
and psychologic factors. Clin Gastroenterol Hepatol 5: 201–208.
43. Ghoshal UC, Shukla R, Ghoshal U, Gwee KA, Ng SC, et al. (2012) The gut
microbiota and irritable bowel syndrome: friend or foe? Int J Inflam 2012:
151085.
44. Xiao S, Fei N, Pang X, Shen J, Wang L, et al. (2013) A gut microbiota-targeted
dietary intervention for amelioration of chronic inflammation underlying
metabolic syndrome. FEMS Microbiol Ecol: (in press. doi: 10.1111/1574–
6941.12228).
45. D’Aversa F, Tortora A, Ianiro G, Ponziani FR, Annicchiarico BE, et al. (2013)
Gut microbiota and metabolic syndrome. Intern Emerg Med 8 Suppl 1: S11–15.
46. Gulcan E, Taser F, Toker A, Korkmaz U, Alcelik A (2009) Increased frequency
of prediabetes in patients with irritable bowel syndrome. Am J Med Sci 338:
116–119.
47. Shimazu T, Kuriyama S, Hozaw a A, Ohmori K, Sato Y, et al. (2007) Dietary
patterns and cardiovascular disease mortality in Japan: a prospective cohort
study. Int J Epidemiol 36: 600–609.
Irritable Bowel Syndrome & Metabolic Syndrome
PLOS ONE | www.plosone.org 6 November 2014 | Volume 9 | Issue 11 | e112289
... Other studies have also reported associations between impaired glucose metabolism and FSD. Elevated fasting glucose levels have been observed in patients with FM/CWP, CFS, and IBS (Bayrak, 2020;Guo et al., 2014;Kim et al., 2021;Maloney et al., 2010;Rus et al., 2023;Stehlik et al., 2018) and elevated HbA1c has been observed in patients with FM and IBS (Bayrak, 2020;Pappolla et al., 2021). Elevated fasting insulin has been reported in patients with IBS (Furgala et al., 2023) and increased insulin resistance has been reported in patients with IBS, FM, and CFS (Bayrak, 2020;Guo et al., 2014;Pappolla et al., 2021). ...
... Elevated fasting glucose levels have been observed in patients with FM/CWP, CFS, and IBS (Bayrak, 2020;Guo et al., 2014;Kim et al., 2021;Maloney et al., 2010;Rus et al., 2023;Stehlik et al., 2018) and elevated HbA1c has been observed in patients with FM and IBS (Bayrak, 2020;Pappolla et al., 2021). Elevated fasting insulin has been reported in patients with IBS (Furgala et al., 2023) and increased insulin resistance has been reported in patients with IBS, FM, and CFS (Bayrak, 2020;Guo et al., 2014;Pappolla et al., 2021). Furthermore, hyperglycemia is related to one of the primary symptoms of FSD, i.e., persistent fatigue (Goedendorp et al., 2014). ...
... Furthermore, hyperglycemia is related to one of the primary symptoms of FSD, i.e., persistent fatigue (Goedendorp et al., 2014). Opposing findings have also been reported, showing no association between FSD and fasting glucose in IBS or CWP/FM (Gerdle et al., 2014;Guo et al., 2014;Rus et al., 2023). Except for one general population-based longitudinal study of IBS among adult Japanese (Guo et al., 2014), all the mentioned studies were conducted in highly specialized clinical settings analyzing only one type of FSD delimitation at a time, which does increase the risk of results being influenced by selection bias. ...
... Sugar has not only an adverse effect on GI symptoms but is also associated with overweight and obesity [43], leading to several diseases including metabolic diseases, pain hypersensitivity, and malignancies [44,45]. A systematic review has shown obesity to be a risk factor for IBS [46], and IBS was associated with the metabolic syndrome in a large population-based study [47]. This underlines the importance of reduced weight and blood pressure in IBS, and not only improvement of symptoms. ...
... Questions[40][41][42][43][44][45][46][47][48] in the Swedish version of the Rome IV questionnaire was used, after having received license from The Rome Foundation, Inc. Raleigh, NC, USA[25]. ...
Article
Full-text available
A diet with low content of fermentable oligo-, di-, and monosaccharides and polyols (FODMAP) is established treatment for irritable bowel syndrome (IBS), with well-documented efficiency. A starch- and sucrose-reduced diet (SSRD) has shown similar promising effects. The primary aim of this randomized, non-inferiority study was to test SSRD against low FODMAP and compare the responder rates (RR = ∆Total IBS-SSS ≥ −50) to a 4-week dietary intervention of either diet. Secondary aims were to estimate responders of ≥100 score and 50% reduction; effects on extraintestinal symptoms; saturation; sugar craving; anthropometric parameters; and blood pressure. 155 IBS patients were randomized to SSRD (n = 77) or low FODMAP (n = 78) for 4 weeks, with a follow-up 5 months later without food restrictions. The questionnaires Rome IV, IBS-severity scoring system (IBS-SSS), and visual analog scale for IBS (VAS-IBS) were completed at baseline and after 2 and 4 weeks and 6 months. Weight, height, waist circumference, and blood pressures were measured. Comparisons were made within the groups and between changes in the two groups. There were no differences between groups at baseline. The responder rate of SSRD was non-inferior compared with low FODMAPs at week 2 (79.2% vs. 73.1%; p = 0.661;95% confidence interval (CI) = −20–7.2) and week 4 (79.2% vs. 78.2%; p = 1.000;95%CI = −14–12). Responder rate was still high when defined stricter. All gastrointestinal and extraintestinal symptoms were equally improved (p < 0.001 in most variables). SSRD rendered greater reductions in weight (p = 0.006), body mass index (BMI) (p = 0.005), and sugar craving (p = 0.05), whereas waist circumference and blood pressure were equally decreased. Weight and BMI were regained at follow-up. In the SSRD group, responders at 6 months still had lowered weight (−0.7 (−2.5–0.1) vs. 0.2 (−0.7–2.2) kg; p = 0.005) and BMI (−0.25 (−0.85–0.03) vs. 0.07 (−0.35–0.77) kg/m²; p = 0.009) compared with baseline in contrast to non-responders. Those who had tested both diets preferred SSRD (p = 0.032). In conclusion, a 4-week SSRD intervention was non-inferior to low FODMAP regarding responder rates of gastrointestinal IBS symptoms. Furthermore, strong reductions of extraintestinal symptoms were found in both groups, whereas reductions in weight, BMI, and sugar craving were most pronounced following SSRD.
... The increased prevalence of IBS among females with PCOS [6,14] could be explained in several ways including the fluctuation of sex hormones. In the light of this fact, IBS is highly correlated with metabolic syndrome (METs) [15]. Similarly, women with PCOS are at high risk of developing METs [16]. ...
... The results of a review on humans supported these findings and demonstrated that insulin resistance, obesity, dyslipidaemia and hyperandrogenism contributing factors to the metabolic syndrome in PCOS [65]. Although some researchers have supported the association between IBS and METs [15,66], others have found no association between IBS and METs [67]. Subsequent observational studies on the relationship between Mets and IBS and PCOS are needed. ...
Article
Full-text available
Objective Little is known about how polycystic ovary syndrome (PCOS) is linked to irritable bowel syndrome (IBS). This study aimed to review the existing literature regarding the association between PCOS or its symptoms and complications with IBS. Methods In this review, studies that investigated the proposed cross‐link between features of PCOS and IBS were included. This review collectively focused on recent findings on the mechanism and novel insight regarding the association between IBS and PCOS in future clinical practice. An electronic search of PubMed, Scopus, Epistemonikos, Cochrane Library and Google Scholar was performed. We did not restrict the study setting and publication date. Results The existing evidence has not completely answered the question of whether there is an association between PCOS and IBS and vice versa. Six case–control studies (793 women with PCOS and 547 women in the control group) directly assessed the association between PCOS and IBS. The prevalence of IBS among women with PCOS in these studies has ranged from 10% to 52% compared with 5%–50% in control groups. Evidence suggested the common pathways may have contributed to the interaction between IBS and PCOS, including metabolic syndrome, sex hormone fluctuation, dysregulation of neurotransmitters, psychological problems and environmental and lifestyle factors. To date, it is still ambiguous which of the mentioned components largely contributes to the pathogenesis of both. Conclusion Although limited evidence has shown a higher prevalence of IBS in women with PCOS, there are several potential, direct and common indirect pathways contributing to the development of both IBS and PCOS.
... Some studies have shown an association between unfavorable plasma lipid profiles such as high levels of triglycerides and low density lipoprotein (LDL) cholesterol and low levels of high density lipoprotein (HDL) cholesterol in patients with FM [11][12][13], CFS [14,15], and IBS [16], but most of these are smaller case-control studies in highly specialized clinical settings with diverse terminologies and high risk of selection bias. Also, the studies have only examined one delimitation of FSD at the time, ignoring the overlap that exists among the syndromes. ...
... Hypotheses dealing with a possible association between unfavorable lipid profiles and FSD include oxidative stress [14], presence of obesity [13], unfavorable lifestyle [16] and altered response to stress [15]. But the main problem in assessing any real association between FSD and lipid profile is the lack of large-scale, population-based, epidemiological studies, where the various FSD are analyzed simultaneously. ...
Article
Full-text available
Objectives Earlier studies on the association between plasma lipid profiles and functional somatic disorders (FSD) are mainly small case control studies hampered by selection bias and do not consider the great overlap between the various FSDs. The aim of the present study was to investigate the associations between various FSDs and plasma lipid profiles (total cholesterol, HDL cholesterol, non-HDL cholesterol and triglycerides) in a large, unselected population. Design A cross-sectional general population-based study Setting The Danish Study of Functional Somatic Disorders (DanFunD) conducted in 2011–2015 in 10 municipalities in the western part of greater Copenhagen, Denmark. Participants A total of 8,608 men and women aged 18–76 years were included in the analyses. Various delimitations of FSD such as chronic fatigue, chronic widespread pain, irritable bowel, and bodily distress syndrome were measured using validated self-administrated questionnaires. Lipid parameters were measured from fasting plasma samples using colorimetric slide methods with Vitros 4600/5600 Ortho Clinical Diagnostics. Outcome measures Logistic regression analyses were used to calculate possible associations between plasma lipids and the various delimitations of FSD. Associations are presented by OR (95% CI) and shown in boxplots. Results We found a positive association between bodily distress syndrome and triglycerides and non-HDL cholesterol and a negative association with HDL-cholesterol, but no consistent association with total cholesterol. A similar pattern was observed for persons with chronic fatigue, and to some degree for persons with chronic widespread pain, whereas persons with irritable bowel did not show a clear association with the lipid profiles. Conclusion This is the first major study on plasma lipid profiles and FSD indicating an association between some delimitations of FSD and an unfavorable lipid profile. Due to the cross-sectional design, it cannot be determined whether the findings are consequences or determinants of FSD. Further studies–preferable prospective studies—are needed.
... This underlines the importance of reduced weight and blood pressure in IBS, and not only improvement of symptoms. Total sugar and fructose intake are associated with all-cause mortality and cardiovascular disease mortality [36]. Thus, decrease of carbohydrate intake, especially sucrose, is of benefit for the whole society [10]. ...
Preprint
Full-text available
A diet with low content of fermentable oligo-, di-, and monosaccharides and polyols (FODMAP) are established treatment for irritable bowel syndrome (IBS), with well-documented efficiency. A starch- and sucrose-reduced diet (SSRD) has shown similar promising effects. This randomized, non-inferiority study aimed to test SSRD against low FODMAP and compare the responder rates to a 4-week dietary intervention of either diet. 155 IBS patients were randomized to SSRD (n=77) or low FODMAP (n=78) for 4 weeks, with a follow-up 5 months later without food restrictions. The questionnaires Rome IV, IBS-severity scoring system (IBS-SSS), and visual analog scale for IBS (VAS-IBS) were completed at baseline and after 2 and 4 weeks and 6 months. Weight, height, waist circumference, and blood pressures were measured. Comparisons were made within the groups and between changes in the two groups. There were no differences between groups at baseline. The responding rate (RR=∆Total IBS-SSS ≥−50) of SSRD was non-inferior compared with low FODMAPs at week 2 (79.2% vs. 73.1%;p=0.661;95% confidence interval (CI)=-20-7.2) and week 4 (79.2% vs. 78.2%;p=1.000;95%CI=-14-12), with borderline-significance at follow-up (36.4% vs. 42.3%;p=0.252;95%CI=-9.4-21). All gastrointestinal and extraintestinal symptoms were equally improved (p<0.001 in most variables). SSRD rendered greater reductions in weight (p=0.006), body mass index (BMI) (p=0.005), and sugar craving (p=0.05), whereas waist circumference and blood pressure were equally decreased. Weight and BMI were regained at follow-up. In the SSRD group, responders at 6 months still had lowered weight (-0.7 (-2.5-0.1) vs. 0.2 (-0.7-2.2) kg; p=0.005) and BMI (-0.25 (-0.85-0.03) vs. 0.07 (-0.35-0.77) kg/m2; p=0.009) compared with baseline in contrast to non-responders. Those who had tested both diets preferred SSRD (p=0.032). A 4-week SSRD intervention was non-inferior to low FODMAP regarding effects on gastrointestinal and extraintestinal IBS symptoms. Reductions of weight, BMI, and sugar craving were most pronounced following SSRD.
... 38 Research has linked obesity and metabolic syndrome, well-known risk factors for hypertension or heart diseases, to disturbances of the intestinal microbiota. 39 In addition, significantly lower resting baroreceptor sensitivity among IBS patients and higher blood pressure, compared with healthy control subjects, were attributed to IBS. 40 Another study suggested that the decrease in baroreceptor sensitivity determined the severity of IBS through increasing diastolic blood pressure level. 41 With regard to metabolic syndrome, studies have suggested that IBS might affect the digestion and absorption of fats in the GIT leading to elevated triglycerides, in addition to impaired absorption of mannitol and sorbitol. ...
Article
Full-text available
Objective To investigate factors related to the risk of developing irritable bowel syndrome (IBS) or Helicobacter pylori infection. Methods This cross-sectional, questionnaire-based study analysed the responses from participants that completed an online questionnaire, which asked about their knowledge of the causes and risk factors associated with IBS and H. pylori infection. Results The study analysed responses from 230 participants: 181 females (of 227 participants; 79.7%) and 190 aged 18–40 years (of 228; 83.3%). Of the 230 participants, 40 (17.4%) had been diagnosed by a physician with IBS and 57 (24.8%) had been diagnosed with H. pylori infection. Of 226 participants, 93 (41.2%) had self-medicated with antibiotics in the past 6 months for various reasons. The overall mean ± SD knowledge score about IBS and H. pylori infection for the study cohort (n = 230) was 35.8 ± 19.2%. Wald χ²-test analysis demonstrated that chronic diseases, antibiotic use and having an endoscopy were significantly associated with developing IBS. Male sex and chronic diseases were significantly associated with H. pylori infection. Logistic regression analysis showed no relationship between IBS and H. Pylori infection. Conclusion Chronic diseases was the only risk factor common for IBS and H. pylori infection.
... Understanding the implications of our findings requires further research, because the relationship between uric acid levels and IBS has not been fully elucidated. However, several studies support a link between purine levels and IBS subtypes [68][69][70][71], and there are welldocumented associations between high uric acid levels (hyperuricemia) and inflammatory diseases (i.e., gout [72,73], hypertension [74], metabolic syndrome [75], and chronic kidney disease [76]) which are, in turn, associated with IBS or its subtypes [65,[77][78][79]. Furthermore, purinergic receptors are implicated in secretomotor reflexes of the gastrointestinal tract [80][81][82] and are actively pursued as IBS drug targets [83,84]. ...
Preprint
Functional gastrointestinal disorders present diagnostic and therapeutic challenges, and there is a strong need for molecular markers that enable early detection and intervention. Herein, we present an approach to assess an abnormal gut microbiome associated with irritable bowel syndrome using stool-based gut metatranscriptome data from a large adult human population ( n = 80,570). We develop a suite of eight gut microbial functional pathway scores, each of which represents the activity of a set of interacting microbial functional features (based on KEGG orthology) relevant to known gut biochemical activities. We use a normative approach within a subpopulation ( n = 9,350) to define “Good” and “Not Optimal” activities for these functional pathway scores. We hypothesize that Not Optimal scores are associated with irritable bowel syndrome (IBS) and its subtypes (i.e., IBS-Constipation, IBS-Diarrhea, IBS-Mixed Type). We show that Not Optimal functional pathway scores are associated with higher odds of IBS or its subtypes within an independent cohort ( n = 71,220) using both the Rome IV Diagnostic Questionnaire as well as self-reported phenotypes. Rather than waiting to diagnose IBS after symptoms appear, these functional scores can help to provide early health insights into molecular pathways that may lead to IBS. These molecular endpoints could also assist with measuring the efficacy of practical interventions, developing related algorithms, providing personalized nutritional recommendations, diagnostics, and treatments for gastrointestinal disorders like IBS. Graphical Abstract
... Triglycerides are the major form of intracellular and plasma fatty acids storage and transport, which stores most of the energy for regulating physiological functions 26 . However, abnormal levels of triglyceride lead to several kinds of diseases, including coronary heart disease, acute pancreatitis, metabolic syndrome, and microvascular complications in patients with diabetes such as diabetic nephropathy and other diseases 10,[27][28][29] . ...
Article
Full-text available
Although functional gastrointestinal disorder (FGID) is a common clinical condition, its risk factors remain unclear. We performed a Mendelian randomization study to explore the association between plasma lipids and the risk of FGID. Instrumental variables closely related to six plasma lipids were obtained from the corresponding genome-wide association studies, and summary-level data on FGID, including irritable bowel syndrome (IBS) and functional dyspepsia (FD), were extracted from the FinnGen study. The primary inverse variance weighted method and other supplementary analyses were used to evaluate the causal relationship between diverse plasma lipids and FGID. For each increase in the standard deviation of triglyceride levels, there was a 12.0% increase in the risk of IBS rather than that of FD. Low- and high-density lipoprotein cholesterol, total cholesterol, apolipoprotein A, and apolipoprotein B levels were not associated with the risk of IBS or FD. Through this study, we identified the causal role of triglycerides in the pathogenesis of IBS, which could benefit further basic and clinical research.
Article
The global prevalence of prediabetes is expected to reach 8.3% (587 million people) by 2045, with 70% of people with prediabetes developing diabetes during their lifetimes. We aimed to classify community‐dwelling adults with a high risk for prediabetes based on prediabetes‐related symptoms and to identify their characteristics, which might be factors associated with prediabetes. We analyzed homecare nursing records ( n = 26,840) of 1628 patients aged over 20 years. Using a natural language processing algorithm, we classified each nursing episode as either low‐risk or high‐risk for prediabetes based on the detected number and category of prediabetes‐symptom words. To identify differences between the risk groups, we employed t ‐tests, chi‐square tests, and data visualization. Risk factors for prediabetes were identified using multiple logistic regression models with generalized estimating equations. A total of 3270 episodes (12.18%) were classified as potentially high‐risk for prediabetes. There were significant differences in the personal, social, and clinical factors between groups. Results revealed that female sex, age, cancer coverage as part of homecare insurance coverage, and family caregivers were significantly associated with an increased risk of prediabetes. Although prediabetes is not a life‐threatening disease, uncontrolled blood glucose can cause unfavorable outcomes for other major diseases. Thus, medical professionals should consider the associated symptoms and risk factors of prediabetes. Moreover, the proposed algorithm may support the detection of individuals at a high risk for prediabetes. Implementing this approach could facilitate proactive monitoring and early intervention, leading to reduced healthcare expenses and better health outcomes for community‐dwelling adults.
Article
Full-text available
Background: Irritable bowel syndrome (IBS) is associated with obesity and metabolic syndrome. IBS and non-alcoholic fatty liver disease (NAFLD) are highly prevalent entities worldwide and may share similar mechanisms including gut dysbiosis, impaired intestinal mucosal barrier and immune system activation. Aim: To systematically review their association according to the Preferred Reporting Items for Systemic Review and Meta-analyses guidelines. Methods: PubMed, EMBASE and Cochrane Database of Systematic Reviews were searched for relevant papers. Manual searches were also performed. Results: Six studies were included. Both IBS and NAFLD subjects had significantly more metabolic risk factors like hypertension, obesity, dyslipidaemia and diabetes. Our review showed that 23.2% to 29.4% of NAFLD patients had IBS. IBS was significantly higher in NAFLD patients compared with patients without NAFLD (23.2% vs 12.5%, P < 0.01). A higher proportion of IBS patients had NAFLD (65.8% to 74.0%). IBS patients were three times more likely to have NAFLD compared with non-IBS patients (P < 0.001). Two studies showed a significant correlation between the severity of IBS and NAFLD. The proportion of NAFLD subjects with IBS increased with NAFLD severity. Conclusion: Further prospective studies are warranted to evaluate the relationship and shared pathways between IBS and NAFLD, potentially leading to the development of future therapeutics.
Article
Full-text available
Não existe consenso sobre a estratégia nutricional mais adequada para tratar a Síndrome Metabólica (SM), de tal forma que ocorra redução do risco cardiovascular. O presente estudo foi desenhado para avaliar a força de evidência dos benefícios de diferentes intervenções nutricionais na remissão da SM. A busca virtual foi realizada nas bases de dados Medline, Cochrane Library e PubMed, de ensaios clínicos randomizados publicados no período entre 1999 a 2009, em qualquer língua, em indivíduos com 18 anos ou mais e diagnóstico de SM, independente do critério. O operador booleano and foi utilizado na combinação dos MeSH terms "Metabolic Syndrome", "Síndrome x Metabólica" e "Metabolic Syndrome X"; dos entry terms "Dysmetabolic Syndrome X", Metabolic Cardiovascular Syndrome", "Metabolic X Syndrome", "Syndrome X, Metabolic" adicionados dos termos "diet", "intervention and diet", "treatment and diet" e "supplementation". Para cada estudo incluído na revisão foi estimada a Prevalência de SM e o Cálculo da Eficácia após o período de seguimento. Medidas de risco relativo para cada estudo foram descritas pelo Forest Plot. Foram identificados 131 artigos, os quais após critérios de elegibilidade resultaram em 15 estudos. Estes foram separados em quatro grupos: dieta normocalórica associada a exercícios; dieta normocalórica isolada; dieta hipocalórica associada a exercícios; e dieta hipocalórica isolada. Os ensaios com dieta hipocalórica associada à prática de exercícios apresentaram valores mais elevados de eficácia, colaborando para ressaltar os aspectos globais da mudança do estilo de vida no tratamento da SM, onde a alimentação saudável e reduzida em calorias deve ser complementada com a prática de atividade física.
Article
Full-text available
Chronic inflammation induced by endotoxin from a dysbiotic gut microbiota contributes to the development of obesity-related metabolic disorders. Modification of gut microbiota by a diet to balance its composition becomes a promising strategy to help manage obesity. A dietary scheme based on whole grains, traditional Chinese medicinal foods, and prebiotics (WTP diet) was designed to meet human nutritional needs as well as balance the gut microbiota. Ninety-three of 123 central obese volunteers (BMI ≥28 kg m(-2) ) completed a self-controlled clinical trial consisting of 9 weeks intervention on WTP diet followed by a 14 weeks maintenance period. The average weight loss reached 5.79±4.64 kg (6.62±4.94%), in addition to improvement of insulin sensitivity, lipid profiles, and blood pressure. Pyrosequencing of fecal samples showed that phylotypes related to endotoxin-producing opportunistic pathogens of Enterobacteriaceae and Desulfovibrionaceae were reduced significantly, while those related to gut barrier-protecting bacteria of Bifidobacteriaceae increased. Gut permeability, measured as lactulose/mannitol ratio, was decreased compared to the baseline. Plasma endotoxin load as lipopolysaccharide-binding protein was also significantly reduced, with concomitant decrease of tumor necrosis factor-α, interleukin-6, and an increase in adiponectin. These results suggest that modulation of the gut microbiota via dietary intervention may enhance the intestinal barrier integrity, reduce circulating antigen load, and ultimately ameliorate the inflammation and metabolic phenotypes. This article is protected by copyright. All rights reserved.
Article
Full-text available
Objectives: Despite the fact that food and diet are central issues, that concern patients with irritable bowel syndrome (IBS), the current understanding about the association between the intake of certain foods/food groups and the gastrointestinal (GI) symptom pattern, psychological symptoms, and quality of life is poor. The aim of this study was to determine which food groups and specific food items IBS patients report causing GI symptoms, and to investigate the association with GI and psychological symptoms and quality of life. Methods: We included 197 IBS patients (mean age 35 (18-72) years; 142 female subjects) who completed a food questionnaire in which they specified symptoms from 56 different food items or food groups relevant to food intolerance/allergy. The patients also completed questionnaires to assess depression and general anxiety (Hospital Anxiety and Depression), GI-specific anxiety (Visceral Sensitivity Index), IBS symptoms (IBS-Severity Scoring System), somatic symptoms (Patient Health Questionnaire-15), and quality of life (Irritable Bowel Syndrome Quality of Life Questionnaire). Results: In all, 84% of the studied population reported symptoms related to at least one of the food items surveyed. Symptoms related to intake of food items with incompletely absorbed carbohydrates were noted in 138 (70%) patients; the most common were dairy products (49%), beans/lentils (36%), apple (28%), flour (24%), and plum (23%). Of these, 58% experienced GI symptoms from foods rich in biogenic amines, such as wine/beer (31%), salami (22%), and cheese (20%). Histamine-releasing foods, such as milk (43%), wine/beer (31%), and pork (21%), were also considered causes of symptoms in IBS patients. GI symptoms were also frequently reported after intake of fried and fatty foods (52%). With increasing IBS symptom severity, patients reported more food items responsible for their GI symptoms (P=0.004), and this was also found in patients with more severe somatic symptoms (P<0.0001). Women tended to report more food items causing symptoms than men (P=0.06). A high number of food items causing GI symptoms was also associated with reduced quality of life and this was significant for the following domains: sleep (r=-0.25; P=0.001), energy (r=-0.21; P=0.005), food (r=-0.29; P<0.001), social functioning (r=-0.23; P=0.001), and physical status (r=-0.16; P<0.05). However, the number of food items reported to provoke GI symptoms was unrelated to body mass index, age, IBS subtype, anxiety, depression, or GI-specific anxiety. Conclusions: The majority of IBS patients believe that certain food items are important triggers of their GI symptoms. This is especially true for foods containing carbohydrates and fat, and also may be relevant for histamine-releasing food items and foods rich in biogenic amines. Self-reported food intolerance is associated with high symptom burden and reduced quality of life.
Article
Irritable bowel syndrome (IBS) is the most common disorder diagnosed by gastroenterologists and one of the more common ones encountered in general practice. The overall prevalence rate is similar (approximately 10%) in most industrialized countries; the illness has a large economic impact on health care use and indirect costs, chiefly through absenteeism. IBS is a biopsychosocial disorder in which 3 major mechanisms interact: psychosocial factors, altered motility, and/or heightened sensory function of the intestine. Subtle inflammatory changes suggest a role for inflammation, especially after infectious enteritis, but this has not yet resulted in changes in the approach to patient treatment. Treatment of patients is based on positive diagnosis of the symptom complex, limited exclusion of underlying organic disease, and institution of a therapeutic trial. If patient symptoms are intractable, further investigations are needed to exclude specific motility or other disorders. Symptoms fluctuate over time; treatment is often restricted to times when patients experience symptoms. Symptomatic treatment includes supplementing fiber to achieve a total intake of up to 30 g in those with constipation, those taking loperamide or other opioids for diarrhea, and those taking low-dose antidepressants or infrequently using antispasmodics for pain. Older conventional therapies do not address pain in IBS. Behavioral psychotherapy and hypnotherapy are also being evaluated. Novel approaches include alosetron; a 5-HT3 antagonist, tegaserod, a partial 5-HT4 agonist, κ-opioid agonists, and neurokinin antagonists to address the remaining challenging symptoms of pain, constipation, and bloating. Understanding the brain-gut axis is key to the eventual development of effective therapies for IBS.
Article
To investigate the prevalence and distribution of metabolic syndrome (MetS) and the impact of exercise, smoking, and educational level on the risk of MetS in a southern Chinese population. A cross-sectional study was conducted in Zhuhai City, China from June to August 2012. Data on exercise, smoking, and educational level, anthropometric parameters, blood pressure, lipid, and glucose levels were collected. The prevalence of MetS (as defined by the International Diabetes Federation) was determined. Data necessary to evaluate MetS, the socio-economic characteristics, and lifestyle were obtained for 4645 subjects aged 18-75 years old. A total of 19.8% of the participants had MetS. The adjusted odds of having MetS were lower among males (adjusted odds: 0.75; 95% confidence interval [CI]: 0.57-1.01) compared with females. Those participants who currently smoked had a higher risk of developing MetS compared with non-smokers (adjusted odds: 1.61; 95% CI: 1.13-2.50). Those who had no physical exercise had a higher risk of developing MetS compared with those who physically exercised more than 60 minutes/day (adjusted odds: 1.51; 95% CI: 1.12-2.23;). Compared with those with no education, every category of attained educational level had a lower risk of developing MetS (p<0.001). The findings in this study revealed that current smokers had a greater risk of developing MetS compared with non-smokers. Increased physical activity and higher levels of education attained served as protective factors for the population.
Article
Sorbitol and mannitol are naturally-occurring polyol isomers. Although poor absorption and induction of gastrointestinal symptoms by sorbitol are known, the properties of mannitol are poorly described. We aimed to expand data on food composition of these polyols, and to compare their absorptive capacities and symptom induction in patients with irritable bowel syndrome (IBS) and healthy individuals. Food samples were analysed for sorbitol and mannitol content. The degree of absorption measured by breath hydrogen production and gastrointestinal symptoms (visual analogue scales) was evaluated in a randomised, double-blinded, placebo-controlled study in 21 healthy and 20 IBS subjects after challenges with 10 g of sorbitol, mannitol or glucose. Certain fruits and sugar-free gum contained sorbitol, whereas mannitol content was higher in certain vegetables. Similar proportions of patients with IBS (40%) and healthy subjects (33%) completely absorbed sorbitol, although more so with IBS absorbed mannitol (80% versus 43%; P = 0.02). Breath hydrogen production was similar in both groups after lactulose but was reduced in patients with IBS after both polyols. No difference in mean (SEM) hydrogen production was found in healthy controls after sorbitol [area-under-the-curve: 2766 (591) ppm 4 h(-1) ] or mannitol [2062 (468) ppm 4 h(-1) ] but, in patients with IBS, this was greater after sorbitol [1136 (204) ppm 4 h(-1) ] than mannitol [404 (154) ppm 4 h(-1) ; P = 0.002]. Overall gastrointestinal symptoms increased significantly after both polyols in patients with IBS only, although they were independent of malabsorption of either of the polyols. Increased and discordant absorption of mannitol and sorbitol occurs in patients with IBS compared to that in healthy controls. Polyols induced gastrointestinal symptoms in patients with IBS independently of their absorptive patterns, suggesting that the dietary restriction of polyols may be efficacious.
Article
Background Food is one of the most commonly reported triggers of irritable bowel syndrome (IBS) symptoms. However, the role of diet in the aetiology and management of IBS has not been clearly established. The present study aimed to examine the dietary practices of Irish patients with IBS and to determine whether these practices increased their vulnerability to nutritional inadequacies. MethodsA questionnaire was completed by 135 IBS patients on their perceptions of the role of diet in their symptoms and whether they restrict their diet according to the symptoms experienced. A similar questionnaire was used to investigate the perceptions of 111 healthy subjects to the gastrointestinal symptoms experienced on the consumption of food. ResultsFood was considered to cause or worsen their gastrointestinal symptoms in 89.6% of IBS patients compared to 55% of healthy subjects (P<0.001). Cereal-based foods, predominantly bread or its components, were the most frequently cited (53.3%), and spicy foods (39.3%), vegetables and fatty foods (35.6% for both) also featured prominently. A significantly greater number of patients with IBS reported changing their diet to minimise symptoms compared to healthy controls (91.9% versus 45.5%, P<0.001). In relation to whole food groups, milk products (9.6%), fruit (7.4%) and vegetables (5.2%) were those most commonly restricted, with only a small number of IBS patients seeking professional healthcare advice. Conclusions The majority of IBS patients consider their symptoms to be related to food, and change their diet by limiting the foods that they perceive as problematic, with some restricting whole food groups. Few patients sought professional healthcare advice when implementing dietary change, possibly exposing a considerable number to an increased risk of nutritional deficiency.